| Teva Pharma AG - Lenalidomid-Teva 25 mg, Hartkapseln | | 67460 | | 07 | | Lenalidomid-Teva 25 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 05.11.2019 | | |
| | Composition | | lenalidomidum 25 mg ut lenalidomidi hydrochloridum monohydricum, silica colloidalis anhydrica, cellulosum microcristallinum carmellosum natricum conexum corresp. natrium 0.06 mg, talcum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Lenalidomidum | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lenalidomidum | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Ammoniae Solutio | 30 | | | Cellulosum Microcristallinum Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Per Centum | | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 007 | 21 | 861.14 | 1005.95 | A | LS | Oui |
|
|
